Salicylic acid

Description

No relevant information is available to construct a Description section for the specified SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The drug should be administered as directed by a healthcare professional. Dosage may vary based on the patient's condition and response to treatment. It is essential to follow the prescribed dosage regimen strictly to ensure both efficacy and safety.

Administration of the drug must occur via the specified route as indicated in the prescribing information. The frequency of administration should adhere to the healthcare provider's instructions, which typically involves administration once or twice daily, depending on the specific treatment plan.

Contraindications

Use of this product is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions.

Additionally, the product should not be used if discomfort persists, as this may indicate an underlying issue requiring medical evaluation. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Contact with eyes should be avoided; if exposure occurs, the affected area must be flushed with water for 15 minutes. Inhalation of vapors is also contraindicated, as it may lead to respiratory irritation.

Warnings and Precautions

For external use only, this product must be applied solely to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

General precautions should be observed to ensure safe usage. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided to minimize respiratory irritation. The bottle should be capped tightly after each use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained if the product is swallowed, reinforcing the importance of prompt action in such situations.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects. Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Ibealee Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product has not been evaluated for safety in pregnancy, and its use during this period is not recommended due to potential risks to the fetus. There may be unknown risks associated with the use of salicylic acid during pregnancy, which necessitates caution. Pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and benefits. No specific dosage modifications are provided for pregnant individuals, highlighting the importance of professional guidance in managing treatment during pregnancy.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for IBEALEE WART REMOVER. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk are not established. Healthcare professionals should exercise caution and consider the potential risks and benefits when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is swallowed, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. It is recommended that healthcare providers assess the patient's condition and consider the necessity of supportive care or specific treatment protocols based on the severity of symptoms presented.

Monitoring for any signs of toxicity is advised, and appropriate management strategies should be implemented as dictated by clinical guidelines and the specific circumstances of the case.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients to avoid contact with the eyes; if the product does come into contact with the eyes, they should flush the eyes with water for at least 15 minutes. It is also important to caution patients against inhaling vapors from the product.

Patients should be informed to securely cap the bottle tightly after each use and to store the product in a cool, dry place, away from direct sunlight and heat, ideally at room temperature.

Healthcare providers should encourage patients to stop using the product and seek medical advice if discomfort persists. Additionally, patients with diabetes or poor blood circulation should be advised to consult a doctor before using the product. In the event of accidental ingestion, patients must be instructed to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibealee Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)